adMare BioInnovations is a venture capital firm focused on building and scaling Canadian life sciences companies by identifying breakthrough innovations, particularly novel pre-clinical technologies addressing unmet medical needs. Their strategy involves providing pre-seed and seed-stage investment, along with scientific, commercial, and business development expertise, to translate academic research into viable commercial ventures.
100% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-b (100% of deals).
Portfolio
1
Fund Size
$2.5B
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Kainova Therapeutics | Series B | $32M | Feb 2026 |
Top Co-Investors
Panacea Venture1 shared
Schroders Capital1 shared
Investissement Quebec1 shared
3B Future Health Fund1 shared
Viva BioInnovator1 shared
Last updated: 4 May 2026